Viable Options: Packaging and Partnering for Successful Storage and Transport of Conventional Cold-Chain Vaccines for Covid-19

From the vendor’s website:

Much of the attention today around efforts to stem the global tide of COVID-19 is on the shipment and distribution of promising vaccine candidates from Pfizer and Moderna. However, vaccines such as these, made from mRNA, come with strict storage requirements, necessitating the need for specialized freezers that maintain super cold or deep-frozen temperatures. These complications could delay distribution in rural areas and developing countries, many of which do not have the required cryogenic capacity or funding.

Supply-chain industry leaders are stepping up to the challenge, including the anticipated increase in demand for refrigerated storage capacity, air freight, and cargo visibility. As strategic planning among manufacturers and logistics partners commences, this webinar will serve as a platform to discuss service offerings and explore the most effective possible solutions.